CDKN2A and meningioma: Interestingly meningiomas with CDKN2A/B deletions also appeared to have worse outcomes compared to CDKN2A/B intact/wt meningiomas in each molecular group (MG) except for in MG4, which are already comprised of the most biologically aggressive meningioma cases (Supplementary Fig. 2h).